Analysts’ updated eps estimates for Friday, March 14th:
Applied Optoelectronics (NASDAQ:AAOI) had its buy rating reissued by analysts at Rosenblatt Securities. The firm currently has a $36.00 target price on the stock.
Apple (NASDAQ:AAPL) had its outperform rating reissued by analysts at Wedbush. The firm currently has a $325.00 price target on the stock.
Akebia Therapeutics (NASDAQ:AKBA) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $7.50 target price on the stock.
Allogene Therapeutics (NASDAQ:ALLO) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. The firm currently has a $14.00 target price on the stock.
Allogene Therapeutics (NASDAQ:ALLO) had its outperform rating reiterated by analysts at Royal Bank of Canada. The firm currently has a $10.00 target price on the stock.
Aemetis (NASDAQ:AMTX) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $28.00 target price on the stock.
Atyr PHARMA (NASDAQ:ATYR) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $35.00 price target on the stock.
Build-A-Bear Workshop (NYSE:BBW) had its buy rating reaffirmed by analysts at DA Davidson. They currently have a $50.00 target price on the stock.
Blink Charging (NASDAQ:BLNK) had its hold rating reiterated by analysts at Needham & Company LLC.
Blink Charging (NASDAQ:BLNK) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $8.00 target price on the stock.
Candel Therapeutics (NASDAQ:CADL) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $19.00 target price on the stock.
Compass (NYSE:COMP) had its buy rating reaffirmed by analysts at Needham & Company LLC. They currently have a $12.00 target price on the stock.
CareTrust REIT (NASDAQ:CTRE) had its underperform rating reiterated by analysts at Wedbush. Wedbush currently has a $26.00 target price on the stock.
Torrid (NYSE:CURV) had its market perform rating reiterated by analysts at Telsey Advisory Group. Telsey Advisory Group currently has a $5.00 target price on the stock.
DICK’S Sporting Goods (NYSE:DKS) had its outperform rating reaffirmed by analysts at Telsey Advisory Group. They currently have a $250.00 target price on the stock.
DocuSign (NASDAQ:DOCU) had its hold rating reiterated by analysts at Needham & Company LLC.
DocuSign (NASDAQ:DOCU) had its sector perform rating reaffirmed by analysts at Royal Bank of Canada. The firm currently has a $90.00 target price on the stock.
DocuSign (NASDAQ:DOCU) had its neutral rating reissued by analysts at Wedbush. The firm currently has a $100.00 target price on the stock.
EVE (NYSE:EVEX) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. The firm currently has a $5.00 price target on the stock.
Flutter Entertainment (LON:FLTR) had its buy rating reiterated by analysts at Berenberg Bank. They currently have a £247 ($319.95) price target on the stock.
1-800-FLOWERS.COM (NASDAQ:FLWS) had its neutral rating reissued by analysts at DA Davidson. DA Davidson currently has a $7.50 target price on the stock.
Fabrinet (NYSE:FN) had its buy rating reiterated by analysts at Rosenblatt Securities. The firm currently has a $285.00 target price on the stock.
Generation Bio (NASDAQ:GBIO) had its outperform rating reissued by analysts at Wedbush. They currently have a $5.00 price target on the stock.
Generation Bio (NASDAQ:GBIO) had its buy rating reiterated by analysts at Needham & Company LLC. Needham & Company LLC currently has a $8.00 price target on the stock.
Gossamer Bio (NASDAQ:GOSS) had its outperform rating reaffirmed by analysts at Wedbush. The firm currently has a $4.00 price target on the stock.
HealthEquity (NASDAQ:HQY) had its outperform rating reiterated by analysts at Barrington Research. The firm currently has a $112.00 target price on the stock.
HSBC (LON:HSBA) had its buy rating reaffirmed by analysts at Bank of America Co.. They currently have a GBX 1,035 ($13.41) target price on the stock.
IDOX (LON:IDOX) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a GBX 90 ($1.17) price target on the stock.
ImmunoPrecise Antibodies (NASDAQ:IPA) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $7.00 target price on the stock.
KalVista Pharmaceuticals (NASDAQ:KALV) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $20.00 price target on the stock.
Kaltura (NASDAQ:KLTR) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $3.00 target price on the stock.
Kainos Group (LON:KNOS) had its speculative buy rating reissued by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a GBX 1,000 ($12.95) price target on the stock.
Kooth (LON:KOO) had its buy rating reissued by analysts at Canaccord Genuity Group Inc.. They currently have a GBX 580 ($7.51) price target on the stock.
Stride (NYSE:LRN) had its outperform rating reaffirmed by analysts at Barrington Research. They currently have a $140.00 target price on the stock.
Lyra Therapeutics (NASDAQ:LYRA) had its neutral rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $2.00 price target on the stock.
MediciNova (NASDAQ:MNOV) had its buy rating reissued by analysts at D. Boral Capital. They currently have a $9.00 target price on the stock.
N-able (NYSE:NABL) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $10.00 target price on the stock.
National CineMedia (NASDAQ:NCMI) had its outperform rating reissued by analysts at Barrington Research. They currently have a $7.00 target price on the stock.
Netcall (LON:NET) had its buy rating reissued by analysts at Canaccord Genuity Group Inc.. They currently have a GBX 130 ($1.68) target price on the stock.
NRx Pharmaceuticals (NASDAQ:NRXP) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $19.00 target price on the stock.
OSB Group (LON:OSB) had its buy rating reaffirmed by analysts at Shore Capital.
Pharming Group (NASDAQ:PHAR) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $37.00 price target on the stock.
ProQR Therapeutics (NASDAQ:PRQR) had its buy rating reissued by analysts at Chardan Capital. They currently have a $4.00 target price on the stock.
D-Wave Quantum (NYSE:QBTS) had its buy rating reaffirmed by analysts at Benchmark Co.. The firm currently has a $8.00 price target on the stock.
D-Wave Quantum (NYSE:QBTS) had its buy rating reiterated by analysts at Needham & Company LLC. The firm currently has a $8.50 target price on the stock.
Rubrik (NYSE:RBRK) had its overweight rating reissued by analysts at Cantor Fitzgerald. The firm currently has a $85.00 price target on the stock.
Regulus Therapeutics (NASDAQ:RGLS) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $10.00 target price on the stock.
REGENXBIO (NASDAQ:RGNX) had its buy rating reissued by analysts at Chardan Capital. The firm currently has a $52.00 price target on the stock.
Skillz (NYSE:SKLZ) had its outperform rating reiterated by analysts at Wedbush. Wedbush currently has a $15.00 target price on the stock.
Semtech (NASDAQ:SMTC) had its buy rating reiterated by analysts at Needham & Company LLC. The firm currently has a $54.00 target price on the stock.
Emeren Group (NYSE:SOL) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $7.00 price target on the stock.
TScan Therapeutics (NASDAQ:TCRX) had its overweight rating reissued by analysts at Morgan Stanley. The firm currently has a $10.00 price target on the stock.
ServiceTitan (NASDAQ:TTAN) had its buy rating reiterated by analysts at Needham & Company LLC. The firm currently has a $125.00 price target on the stock.
ServiceTitan (NASDAQ:TTAN) had its overweight rating reaffirmed by analysts at Piper Sandler. The firm currently has a $125.00 target price on the stock.
Vanquis Banking Group (LON:VANQ) had its house stock rating reiterated by analysts at Shore Capital.
Westrock Coffee (NASDAQ:WEST) had its buy rating reissued by analysts at Benchmark Co.. Benchmark Co. currently has a $10.00 price target on the stock.
Receive News & Ratings for Applied Optoelectronics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied Optoelectronics Inc and related companies with MarketBeat.com's FREE daily email newsletter.
